Gabapentin reverses mechanical allodynia induced by sciatic nerve ischemia and formalin-induced nociception in mice

Experimental Neurology

Volumn 182, Issue 2, 2003, Pages 427-434

  Gustafsson, Henrik ^b   Flood, Karin ^b   Berge, Odd Geir ^b   Brodin, Ernst ^a   Olgart, Leif ^a   Stiller, Carl Olav ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allodynia; Formalin; Gabapentin; Laser; Mice; Neuropathic pain; Sciatic nerve; Von Frey hair filaments

Indexed keywords

BERYTHROMYCIN; DYE; FORMALDEHYDE; GABAPENTIN;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; ISCHEMIA; LASER; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MAXIMUM PERMISSIBLE DOSE; MOUSE; NOCICEPTION; NONHUMAN; PERIPHERAL NEUROPATHY; PHOTOCHEMISTRY; PHOTOSENSITIZATION; PRIORITY JOURNAL; SCIATIC NERVE; TIME; TOUCH;

EID: 0041663746     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00097-9     Document Type: Article

References (65)

1. Abdi S., Lee D.H., Chung J.M. The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain. Anesth. Analg. 87:1998;1360-1366.
2. Arnér S. Opioids and long-lasting pain conditions 25-year perspective on mechanism-based treatment strategies . Pain Rev. 7:2000;81-96.
3. Attal N. Chronic neuropathic pain mechanisms and treatment . Clin. J. Pain. 16:2000;S118-S130.
4. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., LaMoreaux L., Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus a randomized controlled trial . J. Am. Med. Assoc. 280:1998;1831-1836.
5. 3H]leucine . Anal. Biochem. 255:1998;36-243.
6. Bryans J.S., Wustrow D.J. 3-Substituted GABA analogs with central nervous system activity a review . Med. Res. Rev. 19:1999;149-177.
7. Calcutt N.A., Chaplan S.R. Spinal pharmacology of tactile allodynia in diabetic rats. Br. J. Pharmacol. 122:1997;1478-1482.
8. Chaplan S.R., Pogrel J.W., Yaksh T.L. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J. Pharmacol. Exp. Ther. 269:1994;1117-1123.
9. Chapman V., Suzuki R., Chamarette H.L., Rygh L.J., Dickenson A.H. Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain. 75:1998;261-272.
10. Cesena R.M., Calcutt N.A. Gabapentin prevents hyperalgesia during the formalin test in diabetic rats. Neurosci. Lett. 262:1999;101-104.
11. Coderre T.J., Katz J., Vaccarino A.L., Melzack R. Contribution of central neuroplasticity to pathological pain review of clinical and experimental evidence . Pain. 52:1993;259-285.
12. Coyle D.E., Sehlhorst C.S., Mascari C. Female rats are more susceptible to the development of neuropathic pain using the partial sciatic nerve ligation (PSNL) model. Neurosci. Lett. 186:1995;135-138.
13. Dellemijn P. Are opioids effective in relieving neuropathic pain? Pain. 80:1999;453-462.
14. Dickenson A.H., Sullivan A.F. Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones. Neurosci. Lett. 83:1987;207-211.
15. Field M.J., Oles R.J., Lewis A.S., McCleary S., Hughes J., Singh L. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br. J. Pharmacol. 121:1997;1513-1522.
16. Field M.J., Holloman E.F., McCleary S., Hughes J., Singh L. Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain. J. Pharmacol. Exp. Ther. 282:1997;1242-1246.
17. Field M.J., McCleary S., Hughes J., Singh L. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain. 80:1999;391-398.
18. Field M.J., Hughes J., Singh L. Further evidence for the role of the alpha(2)delta subunit of voltage dependent calcium channels in models of neuropathic pain. Br. J. Pharmacol. 131:2000;282-286.
19. Gazelius B., Cui J.G., Svensson M., Meyerson B., Linderoth B. Photochemically induced ischaemic lesion of the rat sciatic nerve a novel method providing high incidence of mononeuropathy . NeuroReport. 7:1996;2619-2623.
20. Gee N.S., Brown J.P., Dissanayake V.U., Offord J., Thurlow R., Woodruff G.N. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J. Biol. Chem. 271:1996;5768-5776.
21. Hao J.X., Herregodts P., Lind G., Meyerson B., Seiger A., Wiesenfeld-Hallin Z. Photochemically induced spinal cord ischaemia in rats assessment of blood flow by laser Doppler flowmetry . Acta. Physiol. Scand. 151:1994;209-215.
22. Hao J.X., Xu I.S., Xu X.J., Wiesenfeld-Hallin Z. Effects of intrathecal morphine, clonidine and baclofen on allodynia after partial sciatic nerve injury in the rat. Acta Anaesthesiol. Scand. 43:1999;1027-1034.
23. Hao J.X., Blakeman K.H., Yu W., Hultenby K., Xu X.J., Wiesenfeld-Hallin Z. Development of a mouse model of neuropathic pain following photochemically induced ischemia in the sciatic nerve. Exp. Neurol. 163:2000;231-238.
24. Hao J.X., Xu X.J., Urban L., Wiesenfeld-Hallin Z. Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats. Neurosci. Lett. 280:2000;211-214.
25. Hunter J.C., Gogas K.R., Hedley L.R., Jacobson L.O., Kassotakis L., Thompson J., Fontana D.J. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur. J. Pharmacol. 324:1997;153-160.
26. Hwang J.H., Yaksh T.L. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg. Anesth. 22:1997;249-256.
27. Kayser V., Christensen D. Antinociceptive effect of systemic gabapentin in mononeuropathic rats depends on stimulus characteristics and level of test integration. Pain. 88:2000;53-60.
28. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
29. Koltzenburg M. Painful neuropathies. Curr. Opin. Neurol. 11:1998;515-521.
30. Kupers R.C., Nuytten D., De Castro-Costa M., Gybels J.M. A time course analysis of the changes in spontaneous and evoked behaviour in a rat model of neuropathic pain. Pain. 50:1992;101-111.
31. Kupers R., Yu W., Persson J.K., Xu X.J., Wiesenfeld-Hallin Z. Photochemically-induced ischemia of the rat sciatic nerve produces a dose-dependent and highly reproducible mechanical, heat and cold allodynia, and signs of spontaneous pain. Pain. 76:1998;45-59.
32. Liu C.N., Wall P.D., Ben-Dor E., Michaelis M., Amir R., Devor M. Tactile allodynia in the absence of C-fiber activation altered firing properties of DRG neurons following spinal nerve injury . Pain. 85:2000;503-521.
33. Luo, L., Raboisson, P., 2001. Gabapentin and mexiletine inhibit formalin-induced peripheral nerve activity in the rat. Society for Neuroscience 31th annual meeting, San Diego, Abstract no. 615.18.
34. Luo Z.D., Chaplan S.R., Higuera E.S., Sorkin L.S., Stauderman K.A., Williams M.E., Yaksh T.L. Upregulation of dorsal root ganglion α2δ calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J. Neurosci. 21:2001;1868-1875.
35. Luukko M., Konttinen Y., Kemppinen P., Pertovaara A. Influence of various experimental parameters on the incidence of thermal and mechanical hyperalgesia induced by a constriction mononeuropathy of the sciatic nerve in lightly anesthetized rats. Exp. Neurol. 128:1994;143-154.
36. Malmberg A.B., Chen C., Tonegawa S., Basbaum A.I. Preserved acute pain and reduced neuropathic pain in mice lacking PKCγ Science. 278:1997;279-283.
37. Malmberg A.B., Basbaum A.I. Partial sciatic nerve injury in the mouse as a model of neuropathic pain behavioral and neuroanatomical correlates . Pain. 76:1998;215-222.
38. Mansikka H., Sheth R.N., DeVries C., Lee H., Winchurch R., Raja S.N. Nerve injury-induced mechanical but not thermal hyperalgesia is attenuated in neurokinin-1 receptor knockout mice. Exp. Neurol. 162:2000;343-349.
39. McGraw T., Kosek P. Erythromelalgia pain managed with gabapentin. Anesthesiology. 86:1997;988-990.
40. McQuay H., Carroll D., Jadad A.R., Wiffen P., Moore A. Anticonvulsant drugs for management of pain a systematic review . Br. Med. J. 311:1995;1047-1052.
41. McQuay H.J., Tramer M., Nye B.A., Carroll D., Wiffen P.J., Moore R.A. A systematic review of antidepressants in neuropathic pain. Pain. 68:1996;217-227.
42. Mellick G.A., Mellick L.B. Reflex sympathetic dystrophy treated with gabapentin. Arch. Phys. Med. Rehabil. 78:1997;98-105.
43. Morello C.M., Leckband S.G., Stoner C.P., Moorhouse D.F., Sahagian G.A. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch. Intern. Med. 159:1999;1931-1937.
44. Newton R.A., Bingham S., Case P.C., Sanger G.J., Lawson S.N. Dorsal root ganglion neurons show increased expression of the calcium channel α2δ-1 subunit following partial sciatic nerve injury. Mol. Brain Res. 95:2001;1-8.
45. Ng G.Y., Bertrand S., Sullivan R., Ethier N., Wang J., Yergey J., Belley M., Trimble L., Bateman K., Alder L., Smith A., McKernan R., Metters K., O'Neill G.P., Lacaille J.C., Hebert T.E. Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol. Pharmacol. 59:2001;144-152.
46. Ochoa J.L., Yarnitsky D. Mechanical hyperalgesias in neuropathic pain patients dynamic and static subtypes . Ann. Neurol. 33:1993;465-472.
47. Pan H.L., Eisenach J.C., Chen S.R. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J. Pharmacol. Exp. Ther. 288:1999;1026-1030.
48. Rice A.S., Maton S. Gabapentin in postherpetic neuralgia a randomised, double blind, placebo controlled study . Pain. 94:2001;215-224.
49. Rosner H., Rubin L., Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin. J. Pain. 12:1996;56-58.
50. Rowbotham M., Harden N., Stacey B., Bernstein P., Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia a randomized controlled trial . J. Am. Med. Assoc. 280:1998;1837-1842.
51. Seltzer Z., Dubner R., Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 43:1990;205-218.
52. Singh L., Field M.J., Ferris P., Hunter J.C., Oles R.J., Williams R.G., Woodruff G.N. The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology. 127:1996;1-9.
53. Sist T., Filadora V., Miner M., Lema M. Gabapentin for idiopathic trigeminal neuralgia report of two cases . Neurology. 48:1997;1467.
54. Stefani A., Spadoni F., Giacomini P., Lavaroni F., Bernardi G. The effects of gabapentin on different ligand- and voltage-gated currents in isolated cortical neurons. Epilepsy Res. 43:2001;239-248.
55. Stiller C.O., Cui J.G., O'Connor W.T., Brodin E., Meyerson B.A., Linderoth B. Release of gamma-aminobutyric acid in the dorsal horn and suppression of tactile allodynia by spinal cord stimulation in mononeuropathic rats. Neurosurgery. 39:1996;367-374.
56. Taylor C.P., Gee N.S., Su T.Z., Kocsis J.D., Welty D.F., Brown J.P., Dooley D.J., Boden P., Singh L. A summary of mechanistic hypothéses of gabapentin pharmacology. Epilepsy Res. 29:1998;233-249.
57. Tjølsen A., Berge O.G., Hunskaar S., Rosland J.H., Hole K. The formalin test an evaluation of the method . Pain. 51:1992;5-17.
58. Vollmer K.O., von Hodenberg A., Kolle E. Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneimittelforschung. 36:1986;830-839.
59. Wallin J., Cui J.G., Yakhnitsa V., Schechtmann G., Meyerson B.A., Linderoth B. Gabapentin and pregabalin suppress tactile allodynia and potentiate spinal cord stimulation in a model of neuropathy. Eur. J. Pain. 6:2002;261-272.
60. Welty D.F., Schielke G.P., Vartanian M.G., Taylor C.P. Gabapentin anticonvulsant action in rats disequilibrium with peak drug concentrations in plasma and brain microdialysate . Epilepsy Res. 16:1993;175-181.
61. Woolf C.J. Molecular signals responsible for the reorganization of the synaptic circuitry of the dorsal horn after peripheral nerve injury the mechanisms of tactile allodynia . Borsook D. Molecular Neurobiology of Pain, Progress in Pain Research Management. Vol. 9:1997;171-200 IASP Press, Seattle.
62. Woolf C.J., Salter M.W. Neuronal plasticity increasing the gain in pain . Science. 288:2000;1765-1769.
63. Xu X.J., Hao J.X., Aldskogius H., Seiger A., Wiesenfeld-Hallin Z. Chronic pain-related syndrome in rats after ischemic spinal cord lesion a possible animal model for pain in patients with spinal cord injury . Pain. 48:1992;279-290.
64. Yaksh T.L. Spinal systems and pain processing development of novel analgesic drugs with mechanistically defined models . Trends Pharmacol. Sci. 20:1999;329-337.
65. Yu W., Kauppila T., Hultenby K., Persson J.K., Xu X.J., Wiesenfeld-Hallin Z. Photochemically-induced ischemic injury of the rat sciatic nerve a light- and electron microscopic study . J. Peripher. Nerv. Syst. 5:2000;209-217.